Parkinson's Disease Review Articles
Parkinson's diaease is a dynamic sensory system issue that influences development. Indications start step by step, here and there beginning with a scarcely observable
tremor in only one hand. Tremors are normal, yet the turmoil likewise usually causes firmness or easing back of development. A confusion of the focal sensory system that influences development, frequently incorporating tremors.Nerve cell harm in the cerebrum causes
dopamine levels to drop, prompting the side effects of Parkinson's.Parkinson's regularly begins with a
tremor in one hand. Different manifestations are sluggish development, solidness and loss of balance.Medication can help control the indications of Parkinson's. Patients generally start building up the illness around age 60, and many live somewhere in the range of 10 and 20 years subsequent to being analyzed. Notwithstanding, a patient's present age and general wellbeing status factor into the exactness of this gauge. Despite the fact that exploration is continuous, to date there is no known fix or approach to forestall Parkinson's malady. Despite the fact that there is no remedy for Parkinson's illness, by distinguishing singular indications and deciding a legitimate course of treatment, the vast majority with the ailment can live charming, satisfying lives.
High Impact List of Articles
-
Pharmacological Modulation of Autophagy for Neuroprotection in Ischaemic Stroke
Alex Gunn, Ayesha Singh, Aipo Diao3, Ruoli Chen
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Pharmacological Modulation of Autophagy for Neuroprotection in Ischaemic Stroke
Alex Gunn, Ayesha Singh, Aipo Diao3, Ruoli Chen
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Neuroprotection with Glycine-2-Methylproline-Glutamate (G-2MePE) after hypoxic-ischemic brain injury in adult rats
Sam Mathai, Paul W. Harris, Margaret A. Brimble, Alistair J. Gunn and Jian Guan
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Neuroprotection with Glycine-2-Methylproline-Glutamate (G-2MePE) after hypoxic-ischemic brain injury in adult rats
Sam Mathai, Paul W. Harris, Margaret A. Brimble, Alistair J. Gunn and Jian Guan
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Acute bioenergetic intervention or pharmacological preconditioning protects neuron against ischemic injury
Shimin Liu, Gehua Zhen, Rung-chi Li and Sylvain Dore
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Acute bioenergetic intervention or pharmacological preconditioning protects neuron against ischemic injury
Shimin Liu, Gehua Zhen, Rung-chi Li and Sylvain Dore
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Novel experimental model for repeated forebrain ischemia-reperfusion
Lei Chen MD, Yu Shang, Eszter Sipos, Kathryn E. Saatman, Guoqiang Yu and Michal Toborek
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Novel experimental model for repeated forebrain ischemia-reperfusion
Lei Chen MD, Yu Shang, Eszter Sipos, Kathryn E. Saatman, Guoqiang Yu and Michal Toborek
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Comment on: Rodent stroke model guidelines for pre-clinical stroke trials (1st edition)
Maureen Walberer, Maria Adele Dennin, Michael Schroeter
Commentary: Journal of Experimental Stroke & Translational Medicine
-
Comment on: Rodent stroke model guidelines for pre-clinical stroke trials (1st edition)
Maureen Walberer, Maria Adele Dennin, Michael Schroeter
Commentary: Journal of Experimental Stroke & Translational Medicine
Relevant Topics in Clinical